Critics say home tests may be unreliable, might delay necessary treatment and could soak up scarce resources. Proponents say they could in the near future play a critical role in tracking COVID-19.
For all three companies, the kits themselves were simply nasal or cheek swabs with written instructions. They had made a connection to laboratories to test the samples and arranged for overnight shipping. A telemedicine doctor would screen consumers and give advice if the test came back positive.
, Dr. Shantanu Nundy – chief medical officer at the health-benefits company Accolade Health – advocated for research to determine whether at-home test kits could be effective for COVID-19. SCAN has received approval for at-home test kits from the Washington Department of Health. But in response to questions, a spokesman said SCAN is not a clinical service. It is a research initiative to better understand the spread of novel coronavirus. It takes samples from people for this research.that he expects government websites soon to screen patients for coronavirus exposure and send those who meet criteria to kiosks, where they would swab their own nostrils under supervision.
“I think there is a big difference between a doctor who knows you and a doctor who is operating from a script,” Campbell said. That’s the route taken by Scanwell, a startup seeking emergency approval from the FDA to roll out a test already being used in China. Similar technology was just purchased by the United Kingdom to provide 7 million people with testing kits.
“The problem here is the federal government had a really botched rollout of testing in general," Patel said, "which is why you ended up with a bunch of commercial labs and then startups that are direct to consumer labs being in this state."Everlywell, however, has not given up.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Coronavirus live updates: FDA gives anti-malaria drugs emergency approval to treat COVID-19CORONAVIRUS LATEST: • FDA gives anti-malaria drugs emergency approval to treat COVID-19. • Pandemic of novel coronavirus has claimed the lives of more than 34,000 people across the globe. • There are now more than 723,000 diagnosed cases of COVID-19.
Read more »
Coronavirus live updates: FDA gives anti-malaria drugs emergency approval to treat COVID-19A pandemic of the novel coronavirus has claimed the lives of more than 35,000 people across the globe. There are now more than 737,000 diagnosed cases of COVID-19, according to data compiled by the Center for Systems Science and Engineering at Johns Hopkins University. With more than 143,000 diagnosed
Read more »
FDA OK's Addition To Stockpile Of Malaria Drugs For COVID-19Chloroquine and hydroxycloroquine got the Food and Drug Administration's go-ahead to be put in the nation's strategic storehouses. But the drugs haven't been approved to treat coronavirus patients.
Read more »
FDA fast tracks new coronavirus treatments and testsDr. Nahid Bhadelia, an infectious disease physician at Boston University School of Medicine, joins Andrea Mitchell to provide her expertise on what the FDA's moves mean for the coronavirus response, as well as potential risk factors to the drugs being approved for use by covid patients.
Read more »
Senators, activists urge FDA to revise blood donation policy for gay, bisexual men amid coronavirus pandemicDemocratic senators and gay rights advocates are calling on the federal government to loosen restrictions on blood donations from gay and bisexual men.
Read more »
FDA Approves Anti-Malarial Drugs Chloroquine And Hydroxychloroquine For Emergency Coronavirus TreatmentThere is little evidence chloroquine and hydroxychloroquine are effective, but the president continues to tout them.
Read more »